Long-term effects of HTLV-1 on brain astrocytes: Sustained expression of Tax-1 associated with synthesis of inflammatory mediators

References

• Ahmed R, Morrison L A, Knipe D M. Persistence of Viruses. Fundamental Virology, B N Fields, D M Knipe, P M Howley. Lipp incott‐Raven Press, Philadelphia 1996; 207–237
   Google Scholar
• Borden P, Heller R A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 1997; 7: 159–178
   PubMed Web of Science ®Google Scholar
• Buckle G J, Hafler D A, Hollsberg P. HTLV.‐I‐induced T‐cell activation. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(Supp l 1)S107–S113
   Google Scholar
• Dubois‐Dalcq M. Viral infections of neuroglial cells. Neuroglia, H Kettenmann, B R Ransom. Oxford University Press, New York 1995; 1010–1025
   Google Scholar
• Eddleston M, Mucke L. Molecular profile of reactive astrocytes ‐ implications for their role in neurologic disease. Neuroscience 1993; 54: 15–36
   PubMed Web of Science ®Google Scholar
• Fox R J, Levin M C, Jacobson S. Tumor necrosis factor alpha expression in the spinal cord of human T‐cell lymphotrophic virus type I associated myelopathy/tropical spastic paraparesis patients ‘see comments’. J Neurovirol 1996; 2: 323–329
   Web of Science ®Google Scholar
• Fridman R, Toth M, Pena D, Mobashery S. Activation of progelatinase B (MMP‐9) by gelatinase A (MMP‐2). Cancer Res 1995; 55: 2548–2555
   PubMed Web of Science ®Google Scholar
• Gessain A, Barin F, Vernant J, Gout O, Maurs L, Calender A, de Thé G. Antibodies to human T‐lymphotropic virus type‐I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–410
   PubMed Web of Science ®Google Scholar
• Giraudon P, Bernard A, Malcus C, Dufay N, Desgranges C, Belin M. Retroviral infection (HTLV.‐I) induces cytokine‐regulated immunomodulation and cytotoxicity of medulloblastoma cells. J Neuropathol Exp Neurol 1995; 54: 165–174
   Google Scholar
• Giraudon P, Buart S, Bernard A, Thomasset N, Belin M F. Extracellular matrix‐remodeling metalloproteinases and infection of the central nervous system with retrovirus human T‐lymphotropic virus type I (HTLV.‐I). Prog Neurobiol 1996; 49: 169–184
   Google Scholar
• Giraudon P, Thomasset N, Bernard A, Verrier B, Belin M F. Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metallo‐proteinase‐2 mRNA (TIMP‐2) in primitive neuroectodermal cells infected with retrovirus HTLV.‐I. Eur J Neurosci 1995; 7: 841–848
   Google Scholar
• Giraudon P, Vernant J C, Confavreux C, Belin M F, Desgranges C. Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV‐1 infected patients with tropical spastic paraparesis. Neurology 1998; 50: 1920
   PubMed Web of Science ®Google Scholar
• Giraudon P, Szymocha R, Buart S, Bernard A, Cartier L, Belin M F, Akaoka H. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases (MMPs) and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV.‐I‐induced neurological disease. J Immunol 2000; 164: 2718–2727
   PubMed Web of Science ®Google Scholar
• Hall G L, Girdlestone J, Compston D A, Wing M G. Recall antigen presentation by gamma‐interferon‐activated microglia results in T cell activation and propagation of the immune response. J Neuroimmunol 1999; 98: 105–111
   Google Scholar
• Hoger T A, Jacobson S, Kawanishi T, Kato T, Nishioka K, Yamamoto K. Accumulation of human T lymphotropic virus (HTLV)‐I‐specific T cell clones in HTLV.‐I‐associated myelopathy/tropical spastic paraparesis patients. J Immunol 1997; 159: 2042–2048
   Google Scholar
• Ijichi S, Izumo S, Eiraku N, Machigashira K, Kubota R, Nagai M, Ikegami N, Kashio N, Umehara F, Maruyama I, et al. An autoaggressive process against bystander tissues in HTLV.‐I‐infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses 1993; 41: 542–547
   Google Scholar
• Jacobson S. Cellular immune responses to HTLV.‐I: immunopathogenic role in HTLV.‐I‐ associated neurologic disease. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(Supp l 1)S100–S106
   Google Scholar
• Jacobson S, Shida H, McFarlin D E, Fauci A S, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV.‐I pX in patients with HTLV.‐I associated neurological disease. Nature 1990; 348: 245–248
   PubMed Web of Science ®Google Scholar
• Jeffery K J, Usuku K, Hall S E, Matsumoto W, Taylor G P, Procter J, Bunce M, Ogg G S, Welsh K I, Weber J N, Lloyd A L, Nowak M A, Nagai M, Kodama D, Izumo S, Osame M, Bangham C R. HLA alleles determine human T‐lymphotropic virus‐I (HTLV.‐I) proviral load and the risk of HTLV.‐I‐associated myelopathy. Proc Natl Acad Sci USA 1999; 96: 3848–3853
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Shimoyama M, Tobinai K, Ito M, Ito S, Ikeda S, Tajima K, Sugimura T. Detection of mRNA for the taxl/rexl gene of human T‐cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T‐cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 5620–5624
   PubMed Web of Science ®Google Scholar
• Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, Sakaki Y, Goto I. Antibody titers to HTLV.‐I‐p40tax protein and gag‐env hybrid protein in HTLV.‐I‐associated myelopathy/ tropical spastic paraparesis: correlation with increased HTLV.‐I proviral DNA load. J Neurol Sci 1992; 107: 98–104
   Google Scholar
• Kitze B, Usuku K, Yashiki S, Ijichi S, Fujiyoshi T, Nakamura M, Izumo S, Osame M, Sonoda S. Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis. Acta Neurol Scand 1996; 94: 287–293
   Google Scholar
• Kubota R, Umehara F, Izumo S, Ijichi S, Matsumuro K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M. HTLV.‐I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV.‐I‐associated myelopathy. J Neuroimmunol 1994; 53: 23–29
   PubMed Web of Science ®Google Scholar
• Kuroda Y, Matsui M, Kikuchi M, Kurohara K, Endo C, Yukitake M, Matsuda Y, Tokunaga O, Komine‐Sakaki A, Kawaguchi R. In situ demonstration of the HTLV.‐I genome in the spinal cord of a patient with HTLV.‐I‐associated myelopathy. Neurology 1994; 44: 2295–2299
   Google Scholar
• Lehky T J, Fox C H, Koenig S, Levin M C, Flerlage N, Izumo S, Sato E, Raine C S, Osame M, Jacobson S. Detection of human T‐lymphotropic virus type I (HTLV.‐I) tax RNA in the central nervous system of HTLV.‐I‐associated myelopathy/tropical spastic paraparesis patients by in situ hybridization ‘see comments’. Ann Neurol 1995a; 37: 167–175
   PubMed Web of Science ®Google Scholar
• Lehky T J, Jacobson S. Induction of HLA class II in HTLV.‐I infected neuronal cell lines. J Neurol Virol 1995b; 1: 145–156
   Web of Science ®Google Scholar
• Lezin A, Buart S, Smadja D, Akaoka H, Bourdonne O, Perret‐Liaudet A, Cesaire R, Belin M F, Giraudon P. Discriminative presence of tissue inhibitor of metalloproteinase TIMP‐3 in association with matrix metalloproteinase‐9 and neopterin, in the cerebrospinal fluid of HTLV.‐I infected neurologic patients vs. healthy virus carriers. AIDS Res Hum Retrovirus 2000; 16, (1 July 2000)
   Google Scholar
• Lindholm P, Reid R, Brady J. Extracellular Taxi protein stimulates tumor necrosis factor‐beta and immunoglobulin kapp a light chain expression in lymphoid cells. J Virol 1992; 66: 1294–1302
   PubMed Web of Science ®Google Scholar
• Loddick S A, Rothwell N J. Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin‐like growth factor‐1. Proc Natl Acad Sci USA 1999; 96: 9449–9451
   Google Scholar
• Massa P T, Wu H. Interferon regulatory factor element and interferon regulatory factor 1 in the induction of major histocompatibility complex class I genes in neural cells. J Interferon Cytokine Res 1995; 15: 799–810
   Google Scholar
• Matsuoka E, Takenouchi N, Hashimoto K, Kashio N, Moritoyo T, Higuchi I, Isashiki Y, Sato E, Osame M, Izumo S. Perivascular T cells are infected with HTLV.‐I in the spinal cord lesions with HTLV.‐I‐associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization. Acta Neuropathol (Red) 1998; 96: 340–346
   PubMed Web of Science ®Google Scholar
• Mendez E, Kawanishi T, Clemens K, Siomi H, Soldan S S, Calabresi P, Brady J, Jacobson S. Astrocyte‐specific expression of human T‐cell lymphotropic virus type 1 (HTLV‐1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV‐1‐specific cytotoxic T cells. J Virol 1997; 71: 9143–9149
   Google Scholar
• Moritoyo T, Izumo S, Moritoyo H, Tanaka Y, Kiyomatsu Y, Nagai M, Usuku K, Sorimachi M, Osame M. Detection of human T‐lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T‐lymphotropic virus type I‐associated myelopathy/tropical spastic paraparesis. J Neurovirol 1999; 5: 241–248
   Web of Science ®Google Scholar
• Moritoyo T, Reinhart T A, Moritoyo H, Sato E, Izumo S, Osame M, Haase A T. Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 1996; 40: 84–90
   PubMedGoogle Scholar
• Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham C R, Izumo S, Osame M. Analysis of HTLV.‐I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV.‐I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4: 586–593
   PubMed Web of Science ®Google Scholar
• Nikcevich K M, Gordon K B, Tan L, Hurst S D, Kroepfl J F, Gardinier M, Barrett T A, Miller S D. IFN‐gamma‐activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen‐specific T cells. J Immunol 1997; 158: 614–621
   Google Scholar
• Oldstone M B. Rous‐Whipp le Award Lecture. Viruses and diseases of the twenty‐first century. Am J Pathol 1993; 143: 1241–1249
   Google Scholar
• Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV.‐I associated myelopathy, a new clinical entity ‘letter’. Lancet 1986; 1: 1031–1032
   PubMed Web of Science ®Google Scholar
• Parker C E, Daenke S, Nightingale S, Bangham C R. Activated, HTLV‐1‐specific cytotoxic T‐lymphocytes are found in healthy seropositive as as well as in patients with tropical spastic paraparesis. Virology 1992; 188: 628–636
   PubMed Web of Science ®Google Scholar
• Petito C K, Kerza‐Kwiatecki A P, Gendelman H E, McCarthy M, Nath A, Podack E R, Shapshak P, Wiley C A. Review: neuronal injury in HIV infection ‘In Process Citation’. J Neurovirol 1999; 5: 327–341
   PubMed Web of Science ®Google Scholar
• Poiesz B J, Ruscetti F W, Gazdar A F, Bunn P A, Minna J D, Gallo R C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T‐cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415–7419
   PubMed Web of Science ®Google Scholar
• Richardson J H, Edwards A J, Cruickshank J K, Rudge P, Dalgleish A G. In vivo cellular tropism of human T‐cell leukemia virus type 1. J Virol 1990; 64: 5682–5687
   PubMed Web of Science ®Google Scholar
• Soos J M, Ashley T A, Morrow J, Patarroyo J C, Szente B E, Zamvil S S. Differential expression of B7 co‐stimulatory molecules by astrocytes correlates with T cell activation and cytokine production ‘In Process Citation’. Int Immunol 1999; 11: 1169–1179
   Google Scholar
• Soos J M, Morrow J, Ashley T A, Szente B E, Bikoff E K, Zamvil S S. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J Immunol 1998; 161: 5959–5966
   Google Scholar
• Suzuki T, Fujisawa J I, Toita M, Yoshida M. The trans‐activator tax of human T‐cell leukemia virus type 1 (HTLV‐1) interacts with cAMP‐responsive element (CRE) binding and CRE modulator proteins that bind to the 21‐base‐pair enhancer of HTLV‐1. Proc Natl Acad Sci USA 1993; 90: 610–614
   PubMed Web of Science ®Google Scholar
• Tan L, Gordon K B, Mueller J P, Matis L A, Miller S D. Presentation of proteolipid protein epitopes and B 7–1‐dependent activation of encephalitogenic T cells by IFN‐gamma‐activated SJL/J astrocytes. J Immunol 1998; 160: 4271–4279
   Google Scholar
• Tillmann M, Wessner R, Wigdahl B. Identification of human T‐cell lymphotropic virus type I 21‐base‐pair repeat‐specific and glial cell‐specific DNA‐protein complexes. J Virol 1994; 68: 4597–4608
   Google Scholar
• Umehara F, Izumo S, Ronquillo A, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV.‐I‐associated myelopathy. J Neuropathol Exp Neurol 1994; 53: 72–77
   PubMedGoogle Scholar
• Watabe K, Saida T, Kim S U. Human and simian glial cells infected by human T‐lymphotropic virus type I in culture. J Neuropathol Exp Neurol 1989; 48: 610–619
   Google Scholar
• Wodarz D, Nowak M A, Bangham C R. The dynamics of HTLV.‐I and the CTL response. Immunol Today 1999; 20: 220–227
   PubMedGoogle Scholar
• Yamada M, Watabe K, Saida T, Kim S U. Increased susceptibility of human fetal astrocytes to human T‐ lymphotropic virus type I in culture. J Neuropathol Exp Neurol 1991; 50: 97–107
   Google Scholar
• Yong V W, Krekoski C A, Forsyth P A, Bell R, Edwards D R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998; 21: 75–80
   PubMed Web of Science ®Google Scholar
• Zhao L J, Giam C Z. Interaction of the human T‐cell lymphotrophic virus type I (HTLV.‐I) transcriptional activator Tax with cellular factors that bind specifically to the 21‐base‐pair repeats in the HTLV.‐I enhancer. Proc Natl Acad Sci USA 1991; 88: 11445–11449
   PubMed Web of Science ®Google Scholar